- UHRA Home
- Browsing by Author
Browsing by Author "Padhani, A.R."
Now showing items 1-2 of 2
-
Magnetic Resonance Imaging Assessment of Squamous Cell Carcinoma of the Anal Canal Before and After Chemoradiation: Can MRI Predict for Eventual Clinical Outcome?
Goh, V.; Gollub, F.K.; Liaw, J.; Wellsted, D.; Przybytniak, I.; Padhani, A.R.; Glynne-Jones, R. (2010)Purpose: To describe the MRI appearances of squamous cell carcinoma of the anal canal before and after chemoradiation and to assess whether MRI features predict for clinical outcome. Methods and Materials: Thirty-five ... -
A Phase I Trial of Radioimmunotherapy with 131I-A5B7 Anti-CEA Antibody in Combination with Combretastatin-A4-Phosphate in Advanced Gastrointestinal Carcinomas
Meyer, T.; Gaya, A.M.; Dancey, G.; Stratford, M.R.L.; Othman, S.; Sharma, S.; Wellsted, D.; Taylor, N.J.; Stirling, J.J.; Poupard, L.; Folkes, L.K.; Chan, P.S.; Pedley, R.B.; Chester, K.A.; Owen, K.; Violet, J.A.; Malaroda, A.; Green, A.J.; Buscombe, J.; Padhani, A.R.; Rustin, G.J.; Begent, R.H. (2009)Purpose: In preclinical models, radioimmunotherapy with 131I-A5B7 anti–carcinoembryonic antigen (CEA) antibody (131I-A5B7) combined with the vascular disruptive agent combretastatin-A4-phosphate (CA4P) produced cures unlike ...